Search
Search
Arshad M. Khanani, MD
Show Description +
Arshad Khanani, MD, MA, shares data from the phase 1 OPTIC trial, which evaluated the intravitreal injection therapy ADVM-022 in patients with wet AMD. Dr. Khanani's summary includes data about safety, visual function, and anatomic changes from various dosages.
Posted: 5/13/2020
Arshad M. Khanani, MD
Arshad Khanani, MD, MA, shares data from the phase 1 OPTIC trial, which evaluated the intravitreal injection therapy ADVM-022 in patients with wet AMD. Dr. Khanani's summary includes data about safety, visual function, and anatomic changes from various dosages.
Posted: 5/13/2020
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARVO: 2020.
Please log in to leave a comment.